BTG International Germany Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
BTG International Germany General Information
Description
Developer of biological drug delivery systems for cancer treatment. The company develops medical devices, cosmetic and pharmaceutical products including radiation delivering pods and drug delivery capsules for the treatment of cancer, enabling healthcare providers to provide better treatment to cancer patients.
Contact Information
Website
cellmed.deCorporate Office
- Industriestrasse 19
- 63755 Alzenau
- Germany
Corporate Office
- Industriestrasse 19
- 63755 Alzenau
- Germany
BTG International Germany Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 23-Sep-2020 | Completed | Generating Revenue | |||
| 3. Merger/Acquisition | 04-Mar-2005 | Completed | Product Development | |||
| 2. Grant | 01-Jan-2001 | $1.72M | $2.72M | Completed | Product Development | |
| 1. Early Stage VC | 01-Jan-2001 | $2.72M | $2.72M | Completed | Product Development |
BTG International Germany Patents
BTG International Germany Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2709868-A1 | Monolithic alginate implants crosslinked in situ | Inactive | 16-Jan-2008 | ||
| EP-2082755-A1 | Monolithic alginate implants networked in situ | Inactive | 16-Jan-2008 | ||
| EP-2229190-A1 | Monolithic in-situ cross-linked alginate implants | Inactive | 16-Jan-2008 | ||
| US-20110097367-A1 | Monolithic in-situ cross-linked alginate implants | Inactive | 16-Jan-2008 | ||
| WO-2009090020-A1 | Monolithic in-situ cross-linked alginate implants | Inactive | 16-Jan-2008 | A61K8/733 |
BTG International Germany Signals
BTG International Germany Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biocompatibles International | Corporation | Majority | ||
| IDP Industrial Development Partners | Growth/Expansion | Minority |
BTG International Germany FAQs
-
When was BTG International Germany founded?
BTG International Germany was founded in 2000.
-
Where is BTG International Germany headquartered?
BTG International Germany is headquartered in Alzenau, Germany.
-
What is the size of BTG International Germany?
BTG International Germany has 20 total employees.
-
What industry is BTG International Germany in?
BTG International Germany’s primary industry is Drug Delivery.
-
Is BTG International Germany a private or public company?
BTG International Germany is a Private company.
-
What is BTG International Germany’s current revenue?
The current revenue for BTG International Germany is .
-
How much funding has BTG International Germany raised over time?
BTG International Germany has raised $2.72M.
-
Who are BTG International Germany’s investors?
Biocompatibles International and IDP Industrial Development Partners have invested in BTG International Germany.
-
When was BTG International Germany acquired?
BTG International Germany was acquired on 23-Sep-2020.
-
Who acquired BTG International Germany?
BTG International Germany was acquired by Boston Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process